Is administration of rituximab at 375 mg/m without splenectomy appropriate for ABO-incompatible renal transplant?
Mitsuhata
N
N
Fujita
R
R
Ito
S
S
Mannami
M
M
Kojima
K
K
D000017:ABO Blood-Group System; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D001787:Blood Group Incompatibility / Q000188:drug therapy*; D006084:Graft Rejection / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D016030:Kidney Transplantation; D000069283:Rituximab; D013156:Splenectomy
D000017:ABO Blood-Group System; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab